Literature DB >> 19869668

STUDIES IN AGGLUTINATION : IV. THE AGGLUTINATION INHIBITION ZONE.

G S Shibley1.   

Abstract

1. The agglutination inhibition zone, artificially produced by heating, has been studied. 2. The phenomenon is specific and is dependent upon the presence in the inhibition zone serum of altered agglutinin (agglutinoid).

Year:  1929        PMID： 19869668      PMCID： PMC2131661          DOI： 10.1084/jem.50.6.825

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  4 in total

1.  THE EFFECT ON SUBSEQUENT AGGLUTINATION OF THE EXPOSURE OF BACTERIA TO HEATED ANTISERUM.

Authors:  F S Jones
Journal:  J Exp Med       Date:  1928-01-31       Impact factor: 14.307

2.  STUDIES IN AGGLUTINATION : III. ON THE MECHANISM OF THE AGGLUTINATION OF BACTERIA BY SPECIFIC AGGLUTINATING SERUM.

Authors:  G S Shibley
Journal:  J Exp Med       Date:  1926-10-31       Impact factor: 14.307

3.  ON THE MECHANISM OF OPSONIN AND BACTERIOTROPIN ACTION : I. CORRELATION BETWEEN CHANGES IN BACTERIAL SURFACE PROPERTIES AND IN PHAGOCYTOSIS CAUSED BY SERA OF ANIMALS UNDER IMMUNIZATION.

Authors:  S Mudd; B Lucké; M McCutcheon; M Strumia
Journal:  J Exp Med       Date:  1929-04-30       Impact factor: 14.307

4.  A QUANTITATIVE STUDY OF THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND PURIFIED HOMOLOGOUS ANTIBODY.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1929-11-30       Impact factor: 14.307
  4 in total
  3 in total

1.  Studies on the microscopic slide-agglutination test for Q fever.

Authors:  B Babudieri
Journal:  Bull World Health Organ       Date:  1958       Impact factor: 9.408

2.  EFFECT OF PHOTO-OXIDATION ON ISOHEMAGGLUTINATING ANTIBODIES.

Authors:  W C Boyd
Journal:  J Exp Med       Date:  1946-02-28       Impact factor: 14.307

3.  STUDIES ON WHOOPING COUGH : I. TYPE-SPECIFIC (S) AND DISSOCIATION (R) FORMS OF HEMOPHILUS PERTUSSIS.

Authors:  G S Shibley; H Hoelscher
Journal:  J Exp Med       Date:  1934-09-30       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.